J. Mialet

Pharmacological characterization of the human 5‐HT4(d) receptor splice variant stably expressed in Chinese hamster ovary cells

F. Lezoualc’h, R. Fischmeister, M. Langlois, 2000, British journal of pharmacology.

Isolation of the serotoninergic 5‐HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6‐glial and CHO cell lines

F. Lezoualc’h, R. Fischmeister, J. Hoebeke, 2000, British journal of pharmacology.

Anti‐SSA/Ro52 autoantibodies blocking the cardiac 5‐HT4 serotoninergic receptor could explain neonatal lupus congenital heart block

D. Isenberg, F. Lezoualc’h, R. Fischmeister, 2000, European journal of immunology.

New arylpiperazine derivatives as antagonists of the human cloned 5-HT(4) receptor isoforms.

F. Lezoualc’h, R. Fischmeister, M. Langlois, 2000, Journal of medicinal chemistry.

Characterization of human 5‐HT4(d) receptor desensitization in CHO cells

F. Lezoualc’h, R. Fischmeister, J. Mialet, 2003, British journal of pharmacology.

Exploration of the ligand binding site of the human 5‐HT4 receptor by site‐directed mutagenesis and molecular modeling

F. Lezoualc’h, R. Fischmeister, J. Hoebeke, 2000, British journal of pharmacology.